Avenue Therapeutics is a pharmaceutical company that focuses on developing and selling products for acute/intensive care hospitals. Their main product is intravenous Tramadol, which is currently in Phase III clinical trials as a treatment for post-operative acute pain. The company is based in New York and was established in 2015.